- Home
- AQST vs MRVI Comparison
AQST vs MRVI Comparison
Compare AQST & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | MRVI |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 559.0M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AQST | MRVI |
|---|---|---|
| Price | $4.22 | $4.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $9.00 | $4.13 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | $67,430,000.00 | ★ $185,743,000.00 |
| Revenue This Year | $10.08 | $12.54 |
| Revenue Next Year | $49.60 | $7.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.22 | $1.99 |
| 52 Week High | $7.55 | $5.00 |
Technical Indicators
Market Signals| Indicator | AQST | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 55.81 |
| Support Level | $3.70 | $3.27 |
| Resistance Level | $4.38 | N/A |
| Average True Range (ATR) | 0.20 | 0.25 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 19.90 | 42.30 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.